These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33330626)

  • 21. Molecular mapping of the RNA Cap 2'-O-methyltransferase activation interface between severe acute respiratory syndrome coronavirus nsp10 and nsp16.
    Lugari A; Betzi S; Decroly E; Bonnaud E; Hermant A; Guillemot JC; Debarnot C; Borg JP; Bouvet M; Canard B; Morelli X; Lécine P
    J Biol Chem; 2010 Oct; 285(43):33230-33241. PubMed ID: 20699222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex.
    Khalili Yazdi A; Li F; Devkota K; Perveen S; Ghiabi P; Hajian T; Bolotokova A; Vedadi M
    SLAS Discov; 2021 Jul; 26(6):757-765. PubMed ID: 33874769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2'-
    Eissa IH; Alesawy MS; Saleh AM; Elkaeed EB; Alsfouk BA; El-Attar AMM; Metwaly AM
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural insight into the recognition of
    Mahalapbutr P; Kongtaworn N; Rungrotmongkol T
    Comput Struct Biotechnol J; 2020; 18():2757-2765. PubMed ID: 33020707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying inhibitors of NSP16-NSP10 of SARS-CoV-2 from large databases.
    Nguyen HL; Thai NQ; Li MS
    J Biomol Struct Dyn; 2023; 41(15):7045-7054. PubMed ID: 36002258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.
    Maurya SK; Maurya AK; Mishra N; Siddique HR
    J Recept Signal Transduct Res; 2020 Dec; 40(6):605-612. PubMed ID: 32476594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential.
    Vithani N; Ward MD; Zimmerman MI; Novak B; Borowsky JH; Singh S; Bowman GR
    Biophys J; 2021 Jul; 120(14):2880-2889. PubMed ID: 33794150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of critical protein-protein interactions of SARS-CoV-2 capping and proofreading molecular machineries towards designing dual target inhibitory peptides.
    Arabi-Jeshvaghani F; Javadi-Zarnaghi F; Ganjalikhany MR
    Sci Rep; 2023 Jan; 13(1):350. PubMed ID: 36611052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mn
    Minasov G; Rosas-Lemus M; Shuvalova L; Inniss NL; Brunzelle JS; Daczkowski CM; Hoover P; Mesecar AD; Satchell KJF
    Sci Signal; 2021 Jun; 14(689):. PubMed ID: 34131072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virtual screening and molecular dynamics simulation for identification of natural antiviral agents targeting SARS-CoV-2 NSP10.
    Zhao H; Liu J; He L; Zhang L; Yu R; Kang C
    Biochem Biophys Res Commun; 2022 Oct; 626():114-120. PubMed ID: 35988295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SS148 and WZ16 inhibit the activities of nsp10-nsp16 complexes from all seven human pathogenic coronaviruses.
    Li F; Ghiabi P; Hajian T; Klima M; Li ASM; Khalili Yazdi A; Chau I; Loppnau P; Kutera M; Seitova A; Bolotokova A; Hutchinson A; Perveen S; Boura E; Vedadi M
    Biochim Biophys Acta Gen Subj; 2023 Apr; 1867(4):130319. PubMed ID: 36764586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-Silico Drug Designing of Spike Receptor with Its ACE2 Receptor and Nsp10/Nsp16 MTase Complex Against SARS-CoV-2.
    Siddiqa MA; Rao DS; Suvarna G; Chennamachetty VK; Verma MK; Rao MVR
    Int J Pept Res Ther; 2021; 27(3):1633-1640. PubMed ID: 33746660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural-Based Virtual Screening of FDA-Approved Drugs Repository for NSP16 Inhibitors, Essential for SARS-COV-2 Invasion Into Host Cells: Elucidation From MM/PBSA Calculation.
    Kumar S; Singh H; Prajapat M; Sarma P; Bhattacharyya A; Kaur H; Kaur G; Shekhar N; Kaushal K; Kumari K; Bansal S; Mahendiratta S; Chauhan A; Singh A; Soloman Singh R; Sharma S; Thota P; Avti P; Prakash A; Kuhad A; Medhi B
    Bioinform Biol Insights; 2023; 17():11779322231171777. PubMed ID: 37533429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated molecular and quantum mechanical approach to identify novel potent natural bioactive compound against 2'-O-methyltransferase (nsp16) of SARS-CoV-2.
    Thomas J; Kumar S; Satija J
    J Biomol Struct Dyn; 2024; 42(4):1999-2012. PubMed ID: 37129206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase.
    Benoni R; Krafcikova P; Baranowski MR; Kowalska J; Boura E; Cahová H
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular dynamic simulations reveal anti-SARS-CoV-2 activity of mitocurcumin by potentially blocking innate immune evasion proteins NSP3 and NSP16.
    Pal D; Checker R; Kutala VK; Sandur SK
    Mol Divers; 2023 Apr; 27(2):635-649. PubMed ID: 35538380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and Inhibition of the Druggable Allosteric Site of SARS-CoV-2 NSP10/NSP16 Methyltransferase through Computational Approaches.
    Faisal S; Badshah SL; Kubra B; Sharaf M; Emwas AH; Jaremko M; Abdalla M
    Molecules; 2022 Aug; 27(16):. PubMed ID: 36014480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NSP16 2'-O-MTase in Coronavirus Pathogenesis: Possible Prevention and Treatments Strategies.
    Chang LJ; Chen TH
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33804957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Porcine Epidemic Diarrhea Virus Deficient in RNA Cap Guanine-N-7 Methylation Is Attenuated and Induces Higher Type I and III Interferon Responses.
    Lu Y; Cai H; Lu M; Ma Y; Li A; Gao Y; Zhou J; Gu H; Li J; Gu J
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32461321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational investigation of potent inhibitors against SARS-CoV-2 2'-O-methyltransferase (nsp16): Structure-based pharmacophore modeling, molecular docking, molecular dynamics simulations and binding free energy calculations.
    Shi L; Wen Z; Song Y; Wang J; Yu D
    J Mol Graph Model; 2022 Dec; 117():108306. PubMed ID: 36063745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.